Financing of non-commercial clinical trials – GRANTS

 

Non-commercial clinical trials may be funded by the NCBR (National Center for Research and Development) within the research and development programs supported by the Center.

 

Contestants will vary according to the requirements of the program, everyone will find something for themselves. There are programs targeted at: natural persons (e.g. doctors) and / or companies or a consortium of companies with
a scientific institution. Businesses are further divided into small, medium and large to equalize opportunities.

Our company offers assistance in obtaining NCBR funds and conducting non-commercial studies (selection of sites, legal regulatory, monitoring). We also support branch opening in Poland, which is often the requirement to apply for
a NCBR grant. All you need is an innovative idea and we can help you implement it.

Once the project has been created, it can be submitted to the appropriate NCBR program, whose requirements will be met by the project. These programs are periodically advertised; upon presentation of the project, a team of appointed experts will evaluate the proposal among others in terms of innovation and usefulness for society. On the basis of such a ranking list, the NCBR Director will issue decisions on co-financing.

 

Areas of research that may receive support and their classification are set out below.

For more information about classification of research and development activities we encourage you to read the article:

http://www.ncbr.gov.pl/gfx/ncbir/userfiles/_public/fundusze_europejskie/inteligentny_rozwoj/publikacje/maselbas_net.pdf

 

The program currently under development is the Intelligent Development Operational Program:

  • Sub-measure 1.1.1 Industrial research and development work implemented by enterprises

Responsible institution: National Center for Research and Development (www.ncbir.pl)

Form of support: grant

Beneficiaries: companies (SME and large)

SME – Small and medium-sized enterprises

Sub-measure 1.1.1

Industrial research and development work implemented by enterprises – called “Fast track”

Addresses of the so-called. "Fast track" are entrepreneurs meeting the criteria of micro, small and medium enterprises (SMEs) and entrepreneurs other than SMEs. They may seek funding for projects involving industrial research and / or development on technological solutions and products conducive to the development of their business and to strengthen their competitive position.

 

The company can carry out R & D work independently by using its own resources or outsourcing work to external entities (scientific units, other companies, scientific networks, scientific and industrial consortia, etc.).

 

Project selection criteria:

Content Criteria:

a) access (YES / NO rating):

  • The project covers industrial research and development or development work, and is concerned with product or process innovation

  • The project is part of KIS[1]

  • Intellectual property does not impede the implementation of the results of the project

  • The management of the project enables its proper implementation / research team and the technical resources of the applicant ensure the proper implementation of the R & D work planned in the project.

b) scored

  • The planned R & D work are adequate and necessary to achieve the project goal, and the risks associated with them are defined

  • The research team and the technical resources of the applicant ensure the proper implementation of the planned R & D work and the management of the project allows for proper implementation.

  • New results of the project

  • Market demand for project results

  • Implementation of the project results is planned on the territory of Poland

Level of funding - competition 1/ 1.1.1 / 2017:​

  • Minimum value of eligible costs:

    • PLN 2 million for SMEs from the district other than Mazowieckie

    • PLN 5 million for SMEs from the Mazowieckie district

    • PLN 12 million for large enterprises
       

  • Maximum value of co-financing:

    • EUR 20 million - if the eligible costs of industrial research account for more than half of the total eligible costs      of the project

    • EUR 15 million  - if the eligible costs of development work represent more than half of the total eligible costs of the project) specified in the Competition Rules
       

  • Support intensivity

    • for industrial research:

      • micro and small enterprises - 70%

      • average - 60%

      • large - 50%

    • for experimental development:

      • micro and small enterprises - 45%

      • average - 35%

      • large - 25%

           + 15% bonus (up to 80% of project cost)

Eligible expenditure:

  • Direct costs

    • Wages (W)

    • Subcontracting (E)

    • Other direct costs (Op), including:

      • costs of apparatus, intangible assets, legal value

      • costs of buildings and grounds

      • other operating expenses

  • Indirect costs

Remuneration - the cost of remuneration including non-wage labor costs, including social security and health insurance contributions for persons engaged in industrial research or development work (research workers, technical workers and other support staff) and technology brokers in proportion to their remuneration associated with the implementation of the project covered by the donation.

 

Subcontracting - commissioning the third party of the project's content and the costs of resources made available by third parties.

 

Within the framework of the project, subcontracting of part of the work without the need to obtain the written approval of the Intermediate Body may be commissioned only by a public university, a public research institute, an institute of the Polish Academy of Sciences or another research and dissemination organization referred to in Art. (2) (83) of Commission Regulation (EU) No 651/2014 of 17 June 2014, which is subject to evaluation of the quality of the scientific or research and development activities of the scientific units referred to Article 41 1 point 1 and art. Article 42 of the Act of 30 April 2010 on Science Financing Rules (Journal of Laws of 2014, item 1620), and received at least grade B.

 

The commissioning of the substantive part of the project (subcontracting) to entities other than those mentioned in the preceding paragraph is possible only after obtaining the written consent of the Intermediate Body.

 

In case of the above-mentioned subcontracting costs, the total eligible expenditure of the project may not exceed 50% of the total eligible costs of the project.

 

Other direct costs 

Costs of research equipment and intangible assets - amortization charges or costs of using:

  • scientific apparatus and other equipment used for research purposes;

  • technical knowledge and patents purchased or used on the basis of licenses obtained from third parties on market terms, i.e. intangible assets and legal value in the form of patents, licenses, know-how, unpatented technical knowledge, expertises, analyzes and research reports, etc. necessary and for the time needed to implement the assisted project.

 

Costs of buildings and grounds - are eligible to the extent and for the duration necessary for the implementation of the project.

This category includes, among others: the following types of costs:

  • ground lease - only installments without interest;

  • perpetual usufruct of land - only perpetual usufruct charges excluding interest;

  • depreciation of buildings - if they are also used for purposes other than project implementation, only the part of the depreciation charge that corresponds to the proportion of use of the buildings for the implementation of the project is eligible.

Other:

  • materials, e.g. raw materials, intermediates, reagents;

  • laboratory equipment (as a rule, all non-durable goods purchased in accordance with the Accounting Act and the adopted accounting policy);

  • costs of maintenance of technological lines, experimental installations, etc. during the period and in proportion of use in the project;

  • renting of laboratory space (i.e. surface adapted for testing, e.g. due to required certificates or security systems used, without research equipment);

  • construction elements and permanently installed in the prototype, pilot installation or demonstration;

  • costs of promotion of the project (publications, website cost, etc. - excluding delegated costs, which should be settled under indirect costs) to 1% of eligible costs of the project;

  • the cost of the external audit if it began after the completion of 50% of the planned expenditure of the project, but not later than 80% of the planned expenditure on the project."
     

Source: Information Desk, European Funds www.funduszeeuropejskie.gov.pl

 

The implementation of scientific projects from the state budget is only gaining speed. It is anticipated that in January 2018, the next edition of the NCBR program dedicated exclusively to medical innovations will be launched: InnoNeuroPharm (details will be available on our website and in the newsletter as soon as the call for proposals is announced).

 

Minister Gowin announces the launch of an additional tranche of state budget funds of PLN 500 million for research in the field of medicine and biotechnology. He pointed out that the offer will be directed mainly to medical universities whose potential is not fully utilized. Gowin believes that medical schools are distinguished by a very high level of scientific research and this is a chance for Poland to develop.

 

We look forward to cooperating with you.